During the COVID-19 pandemic hitting the world and the United States in full force, several national funding opportunities have been issued. These are listed below.

  • Federal Agency Grant and Funding Opportunities related to the COVID-19 Outbreak
  • HHS COVID-19 Funding announcements as of 8-10-20.
  • Additional funding opportunities are provided below.
National Institute of Neurological Disorders and Stroke (NINDS) Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2   Budget varies Applications accepted on a rolling basis from April 6, 2020 until May 9, 2020
Department of Energy (DOE) Invitation for COVID-19 scientific questions

 

DOE Resources Rolling
National Institutes of Health (NIH) NIAID Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)

 

Multi-pronged COVID-19 Funding 

$4,050,000

 

 

 

 

Budget varies

6/29/2020

 

 

 

 

Rolling

National Institutes of Health (NIH) NIAID, NIA Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Not limited 5/13/2020; 9/13/2020; and others
National Institutes of Health (NIH) NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) Not limited See Emergency Notice of Special Interest by IC
National Institutes of Health (NIH) NIEHS NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) – NOT-ES-20-020

 

NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) – NOT-ES-20-017

 

Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral/Social Sciences – NOT-OD-20-097

Expires: May 04, 2021
PA-18-935 Urgent Supplement – (Clinical Trial Optional)
PA-18-591 Supplements to Existing NIH Grants (Clinical Trial Optional); 1 year support for supplements/competitive revisionsRFA-ES-19-011 Time-Sensitive Research in Environ. Health Sciences (R21 No Clinical Trials); Max 2yrs. Expires: April 25, 2020Requests for activities to be completed by the end of the current grant period or no-cost extension; Max $200,000; only existing NIEHS WTP awardees eligible. – NOT-ES-20-017Expires: April 01, 2021
Max two yrs; $100,000 direct costs/yr.; applications accepted on a rolling basis. – NOT-OD-20-097
NIH Grants and Funding guidance
National Institutes of Health (NIH) NIAID, NIGMS Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) Not limited 2/6/2021 (rolling basis)
National Institutes of Health (NIH) NIAID Administrative Supplement Not limited 2/6/2021 (rolling basis)
National Institutes of Health (NIH) NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus $100K direct costs/yr 3/31/2021 (rolling basis)
National Institutes of Health (NIH) NHLBI Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Not limited 10/5/2020 (rolling basis)
National Science Foundation (NSF) RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 Check with program officers
Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) $200,000 (RAPID) & supplemental funding requests Check with program officers
Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Negotiated after white paper stage 10/31/2020
National Center for Advancing Translational Sciences (NCATS) Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus – NOT-TR-20-016 Budgets limited to less than 25% current parent award Expires – 1/26/2022